These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8016910)

  • 1. Recent advances in the development of anticancer drugs that act against signalling pathways.
    Powis G
    Tumori; 1994 Apr; 80(2):69-87. PubMed ID: 8016910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling pathways as targets for anticancer drug development.
    Powis G
    Pharmacol Ther; 1994; 62(1-2):57-95. PubMed ID: 7991648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of phosphatidylinositol signalling as antiproliferative agents.
    Powis G; Phil D
    Cancer Metastasis Rev; 1994 Mar; 13(1):91-103. PubMed ID: 8143348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling targets for anticancer drug development.
    Powis G
    Trends Pharmacol Sci; 1991 May; 12(5):188-94. PubMed ID: 1862534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor and oncogene signalling pathways as targets for rational anticancer drug development.
    Powis G; Kozikowski A
    Clin Biochem; 1991 Oct; 24(5):385-97. PubMed ID: 1760877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs active against growth factor and oncogene phosphatidylinositol signalling pathways.
    Powis G
    Semin Cancer Biol; 1992 Dec; 3(6):343-50. PubMed ID: 1286155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction pathways: new targets in oncology.
    Sweeb RK; Beijnen JH
    Pharm World Sci; 1993 Dec; 15(6):233-42. PubMed ID: 8298582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy.
    Raymond E; Faivre S; Armand JP
    Drugs; 2000; 60 Suppl 1():15-23; discussion 41-2. PubMed ID: 11129168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell membrane and cell signals: new targets for novel anticancer drugs.
    Workman P
    Ann Oncol; 1990; 1(2):100-11. PubMed ID: 1706612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of phospholipid intracellular signaling as antiproliferative agents.
    Powis G; Hill SR; Frew TJ; Sherrill KW
    Med Res Rev; 1995 Mar; 15(2):121-38. PubMed ID: 7739293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the signalling pathways regulated by deubiquitinases for prostate cancer therapeutics.
    Islam MT; Zhou X; Chen F; Khan MA; Fu J; Chen H
    Cell Biochem Funct; 2019 Jul; 37(5):304-319. PubMed ID: 31062387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer drugs acting against signaling pathways.
    Powis G
    Curr Opin Oncol; 1995 Nov; 7(6):554-9. PubMed ID: 8547405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting new anticancer drugs within signalling pathways regulated by the Ras GTPase superfamily (Review).
    Ramírez De Molina A; Rodríguez-González A; Lacal JC
    Int J Oncol; 2001 Jul; 19(1):5-17. PubMed ID: 11408916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
    Wong MS; Sidik SM; Mahmud R; Stanslas J
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraneuronal signalling systems as targets for the development of novel mood-stabilizing drugs.
    Wachtel H
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():198A-199A. PubMed ID: 1498809
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of drug inhibition of signalling molecules.
    Sebolt-Leopold JS; English JM
    Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in understanding the cell death pathways activated by anticancer therapy.
    Kim R
    Cancer; 2005 Apr; 103(8):1551-60. PubMed ID: 15742333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction by Ras-like GTPases: a potential target for anticancer drugs.
    Spaargaren M; Bischoff JR; McCormick F
    Gene Expr; 1995; 4(6):345-56. PubMed ID: 7549466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting intracellular signalling as a strategy for cancer chemoprevention.
    Powis G; Alberts DS
    Eur J Cancer; 1994; 30A(8):1138-44. PubMed ID: 7654446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of alkylphosphocholines as signal transduction inhibitors: experimental and clinical challenges.
    Hilgard P; Pohl J; Engel J
    J Cancer Res Clin Oncol; 1997; 123(5):286-7. PubMed ID: 9201252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.